Skip to main content
FONAR CORP logo

FONAR CORP — Investor Relations & Filings

Ticker · FONR ISIN · US3444374058 US Manufacturing
Open in API
Filings indexed 556 across all filing types
Latest filing 2026-06-03 Regulatory Filings
Country US United States of America
Listing US FONR

About FONAR CORP

https://www.fonar.com/

FONAR Corporation designs, manufactures, sells, and services magnetic resonance imaging (MRI) scanners. A pioneer in the field, the company developed the world's first commercial MRI. Its flagship product is the UPRIGHT® Multi-Position™ MRI, the only scanner capable of imaging patients in various weight-bearing positions, such as standing, sitting, or bending, in addition to the traditional recumbent position. This technology enables the diagnosis of pathologies that may be missed on conventional lie-down MRI systems by scanning patients in the position where they experience symptoms. The scanner's open configuration also accommodates claustrophobic and larger patients.

Recent filings

Filing Released Lang Actions
S-8 POS
Regulatory Filings Classification · 85% confidence The document is a Post-Effective Amendment No. 1 to a Form S-8 registration statement filed with the SEC. It deregisters unissued shares under the Company’s Stock Bonus Plan following a merger. This is a compliance filing with the SEC under the Securities Act of 1933 and does not itself present financial results, governance rules, management changes, or a proxy solicitation. It is not an annual or interim report, not a capital markets update per se, nor a share repurchase notice. It is best classified as a general regulatory filing under the fallback category Regulatory Filings (RNS).
2026-06-03 English
8-K
Regulatory Filings Classification · 94% confidence The document is a Current Report on Form 8-K filed with the SEC. It covers multiple corporate events (merger closing, credit agreement entry, delisting notice, change in control, director resignations, etc.). Form 8-K is a general regulatory compliance filing rather than a standalone financial report, presentation, or proxy statement. It does not contain full financial statements or serve as an earnings release, interim or annual report. Under the taxonomy, this falls under Regulatory Filings (RNS) as a fallback for miscellaneous SEC filings that do not neatly fit another category.
2026-06-03 English
8-K
Regulatory Filings
2026-05-29 English
DEFA14A
Proxy Solicitation & Information Statement
2026-05-21 English
8-K
Regulatory Filings Classification · 85% confidence The document is a U.S. SEC Form 8-K “Current Report” under Item 8.01, providing supplemental disclosures to an already filed definitive proxy statement (Schedule 14A) and Schedule 13E-3 transaction statement in connection with a proposed merger. It is an SEC regulatory announcement rather than the proxy statement itself, an earnings release, or substantive financial report. Therefore it falls under general regulatory filings (RNS).
2026-05-21 English
FORM DEFA14A
Proxy Solicitation & Information Statement
2026-05-12 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.